Breaking News
Investing Pro 0
Final hours: unlock premium data with Claim 60% OFF
Close

AstraZeneca PLC (AZN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
118.250 +0.100    +0.08%
08/12 - Closed. Currency in EUR ( Disclaimer )
  • Volume: 15,587
  • Bid/Ask: 117.500 / 120.250
  • Day's Range: 117.850 - 118.850
Type:  Equity
Market:  Germany
ISIN:  GB0009895292 
WKN:  886455
AstraZeneca 118.250 +0.100 +0.08%

AZN Income Statement

 
Featured here, the Income Statement (earnings report) for AstraZeneca PLC, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Income Statement
Period Ending: 2023
30/09
2023
30/06
2023
31/03
2022
31/12
Total Revenue 11492 11416 10879 11207
Revenue 11492 11416 10879 11207
Other Revenue, Total - - - -
Cost of Revenue, Total 2055 1917 1773 2470
Gross Profit 9437 9499 9106 8737
Total Operating Expenses 8959 8814 8192 9568
Selling/General/Admin. Expenses, Total 4440 5054 4150 4661
Research & Development 2534 2627 2308 2516
Depreciation / Amortization 268 259 260 -4000
Interest Expense (Income) - Net Operating -392 -431 -365 -360
Unusual Expense (Income) - - - -
Other Operating Expenses, Total 54 -612 66 3921
Operating Income 2533 2602 2687 1639
Interest Income (Expense), Net Non-Operating - - - -
Gain (Loss) on Sale of Assets - - 241 155
Other, Net 881 514 184 706
Net Income Before Taxes 1652 2088 2262 778
Provision for Income Taxes 274 268 458 -124
Net Income After Taxes 1378 1820 1804 902
Minority Interest 24 24 22 21
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 1374 1818 1803 901
Total Extraordinary Items - - - -
Net Income 1374 1818 1803 901
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items 1374 1818 1803 901
Dilution Adjustment 1.2 -7.2 -6.6 -3.8
Diluted Net Income 1372.8 1825.2 1809.6 904.8
Diluted Weighted Average Shares 1560 1560 1560 1559
Diluted EPS Excluding Extraordinary Items 0.88 1.17 1.16 0.58
DPS - Common Stock Primary Issue - 0.93 - 1.97
Diluted Normalized EPS 0.891 0.894 0.961 0.541
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AZN Comments

Write your thoughts about Astrazeneca PLC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Oct 28, 2021 0:25
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Double top in reach
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email